Skip to main content

Does Lybalvi cause weight gain?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 27, 2025.

Official Answer by Drugs.com

Key Points

Can Lybalvi Cause Weight Gain?

Yes, weight gain is a possible side effect of Lybalvi. In a 4-week clinical trial, 19% of people taking Lybalvi reported weight gain, compared to 3% of those on a placebo. In a 24-week study, 25% of users reported weight gain.

How Much Weight Might I Gain on Lybalvi?

Not everyone will gain weight from taking Lybalvi. The amount of weight you may gain depends on factors such as your starting weight, diet, exercise habits, other medications, and how long you are taking Lybalvi.

Clinical Trial Data

During a 4-week study of adults with schizophrenia:

In a 24-week clinical trial, patients taking Lybalvi gained around 4.2% of their starting body weight. Around 18% of people taking Lybalvi saw a 10% increase or more in their body weight.

Related questions

How Can I Prevent Weight Gain on Lybalvi?

While weight gain may not always be preventable, certain lifestyle adjustments can help minimize it:

If you notice you are gaining weight while taking Lybalvi, tell your healthcare provider.

This is not all the information you need to know about Lybalvi (olanzapine and samidorphan) for safe and effective use. Review the full Lybalvi (olanzapine and samidorphan) information, and discuss this information and any questions with your doctor or other health care provider.

References

Lybalvi [package insert]. Updated January 2024. Alkermes, Inc. Accessed September 23, 2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32ffddd1-4e2b-45d9-9b36-bb730167ec80

Read next

Mounjaro vs Ozempic: Which is right for you?

Mounjaro and Ozempic are prescription medicines used alongside diet and exercise to help control blood sugar (glucose) levels in adults with type 2 diabetes. Ozempic is also approved to lower the risk of a major cardiovascular event (like a heart attack or stroke) in patients with type 2 diabetes, as well as to reduce the risk of worsening kidney disease and heart-related death in patients with type 2 diabetes. Mounjaro has not yet received these indications, although studies are ongoing.

In a large, 2024 retrospective study in adults with overweight or obesity and treated for type 2 diabetes, Mounjaro led to at least a 5% weight loss within one year in 81.8% of adults compared to 66.5% of those using Ozempic. Continue reading

Zepbound vs. Mounjaro: Comparison Guide for Weight Loss and Diabetes Treatment

Zepbound and Mounjaro contain the same active ingredient (tirzepatide) and both are made by Eli Lilly and Company, but they have different FDA approved uses and insurance coverage. Zepbound is approved for chronic weight management and obstructive sleep apnea (OSA) and Mounjaro is approved for type 2 diabetes.

Continue reading

Ozempic Side Effects to Watch For

The most common Ozempic side effects with Ozempic include stomach problems, like nausea, vomiting, diarrhea, stomach pain and constipation. These tend to be mild-to-moderate and usually clear up in a few weeks in most people. Low blood sugar (hypoglycemia) is also a common side effect (when used with certain other diabetes treatments) and it can be serious. Continue reading

See also:

Related medical questions

Drug information

Related support groups